Objective: To evaluate the value of combined negative sonographic and mammographic findings in patients with palpable breast abnormalities.
Methods: One hundred seventy-two patients with 186 palpable abnormalities who had combined negative sonographic and mammographic findings were prospectively studied. Patients who did not undergo biopsy had imaging and clinical follow-up; the mean follow-up period was 28.9 months (range, 24-33 months).
Results: Twelve patients underwent biopsy; benign histologic diagnoses were reported in all 12 (12 [6.9%] of 172). In the remaining 160 patients who were followed, there was no interval development of breast cancer at the site of the palpable abnormality. The negative predictive value of combined negative mammographic and sonographic findings in a patient with a palpable abnormality of the breast was 100%.
Conclusions: Our findings suggest that in a patient with a palpable abnormality of the breast, the negative predictive value of combined normal sonographic and mammographic findings is very high and is therefore reassuring to the patient.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.7863/jum.2002.21.11.1211 | DOI Listing |
J Breast Imaging
December 2024
Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Cystic neutrophilic granulomatous mastitis (CNGM) is a rare type of granulomatous lobular mastitis (GLM) with a distinct histologic pattern characterized on histopathology by clear lipid vacuoles lined by peripheral neutrophils ("suppurative lipogranulomas"), often containing gram-positive bacilli and strongly associated with Corynebacterial infection (in particular, Corynebacterium kroppenstedtii). Cystic neutrophilic granulomatous mastitis has a distinct histopathologic appearance, but the imaging appearance is less well described and has been limited to case reports and small case series published primarily in pathology literature. Mammographic findings of CNGM include focal asymmetry, skin thickening, and irregular or oval masses.
View Article and Find Full Text PDFRadiology
November 2024
From the Department of Radiology, Seoul National University Hospital, Seoul, South Korea (S.M.H., W.K.M., H.Y.); Department of Radiology, Seoul National University College of Medicine, Seoul, South Korea (S.M.H., W.K.M.); Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, South Korea (S.M.H., W.K.M.); Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea (W.J.C., H.H.K., H.J.K.); Department of Radiological Sciences, University of California, Irvine, Irvine, Calif (W.J.C., J.S.C.); Department of Radiology and Center for Imaging Science, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 06351, South Korea (B.K.H., H.K., J.S.C.); Biomedical Statistics Center, Data Science Research Institute, Research Institute for Future Medicine, Samsung Medical Center, Seoul, Korea (M.J.K., K.K.); and Department of Digital Health, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University School of Medicine, Seoul, South Korea (K.K., J.S.C.).
Background Breast nonmass lesions (NMLs) are observed at screening and diagnostic US. However, knowledge is limited on imaging features of NMLs at screening US. Purpose To identify features of NMLs at screening US that are suspicious for malignancy based on mammographic findings.
View Article and Find Full Text PDFJ Clin Imaging Sci
October 2024
Department of Radiology, University of Kentucky College of Medicine, Lexington, United States.
Eur J Breast Health
July 2024
Department of Radiology University of Miami Miller School of Medicine, Sylvester Cancer Center, and Jackson Memorial Hospital, Miami, FL, USA.
J Res Med Sci
July 2024
Department of Radiology, Mazandaran University of Medical Sciences, Iran.
Background: The aim of this study was to determine whether mammographic and sonographic features of malignant breast lesions are correlated with tumor histologic grade, hormonal receptor, human epidermal growth factor receptor 2 (HER2), and Ki-67 status.
Materials And Methods: In this retrospective study, imaging and histopathological findings of 187 biopsy-proven breast cancer cases from November 2019 to February 2021 were reviewed. The Chi-square test was used to examine the potential correlation between mammographic and sonographic characteristics with histopathological features such as hormonal receptor, HER2 status, Ki-67 labeling index, and histological grade.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!